"local" setting--this is not trivial and we could only prove a weaker (but sufficient) statement that the relevant column

The White House today announced the name of the acting administrator of the Department of Government Efficiency: Amy Gleason, the US government's problem solver in the early days of the data-starved response to the Covid pandemic and a seasoned worker in the health space. The White House named Gleason after it argued in court that Elon Musk is not really the head of DOGE, and faced pressure from a federal judge to say who is. How long Gleason has been the acting administrator, and if Musk was an unofficial one before today's announcement, is unclear. This is Gleason's second time working in US Digital Services, now turned DOGE. In her first tour, which started in 2018 and carried through the frenzied and chaotic pandemic response, she pushed the bounds of existing bureaucracy to meet the crisis' demand.

Histopathological image analysis is a reliable method for prostate cancer identification. In this paper, we present a comparative analysis of two approaches for segmenting glandular structures in prostate images to automate Gleason grading. The first approach utilizes a hand-crafted learning technique, combining Gray Level Co-Occurrence Matrix (GLCM) and Local Binary Pattern (LBP) texture descriptors to highlight spatial dependencies and minimize information loss at the pixel level. For machine driven feature extraction, we employ a U-Net convolutional neural network to perform semantic segmentation of prostate gland stroma tissue. Support vector machine-based learning of hand-crafted features achieves impressive classification accuracies of 99.0% and 95.1% for GLCM and LBP, respectively, while the U-Net-based machine-driven features attain 94% accuracy. Furthermore, a comparative analysis demonstrates superior segmentation quality for histopathological grades 1, 2, 3, and 4 using the U-Net approach, as assessed by Jaccard and Dice metrics. This work underscores the utility of machine-driven features in clinical applications that rely on automated pixel-level segmentation in prostate tissue images.

Significant disparities between the features of natural images and those inherent to histopathological images make it challenging to directly apply and transfer pre-trained models from natural images to histopathology tasks. Moreover, the frequent lack of annotations in histopathology patch images has driven researchers to explore self-supervised learning methods like mask reconstruction for learning representations from large amounts of unlabeled data. Crucially, previous mask-based efforts in self-supervised learning have often overlooked the spatial interactions among entities, which are essential for constructing accurate representations of pathological entities. To address these challenges, constructing graphs of entities is a promising approach. In addition, the diffusion reconstruction strategy has recently shown superior performance through its random intensity noise addition technique to enhance the robust learned representation. Therefore, we introduce H-MGDM, a novel self-supervised Histopathology image representation learning method through the Dynamic Entity-Masked Graph Diffusion Model. Specifically, we propose to use complementary subgraphs as latent diffusion conditions and self-supervised targets respectively during pre-training. We note that the graph can embed entities' topological relationships and enhance representation. Dynamic conditions and targets can improve pathological fine reconstruction. Our model has conducted pretraining experiments on three large histopathological datasets. The advanced predictive performance and interpretability of H-MGDM are clearly evaluated on comprehensive downstream tasks such as classification and survival analysis on six datasets. Our code will be publicly available at https://github.com/centurion-crawler/H-MGDM.

A quick look at census data (more than 11,000 people turn 65 each day in the U.S.), along with my own rough calculations, suggest that several hundred people are turning 70 each day in the great state of California, and every 10 minutes or so, one or more of them email me about their license renewal adventures with the DMV. I get the usual, always entertaining horror stories about testing: ("They put in ridiculous questions that do not pertain to driving," said 75-year-old Dahana Klerer of Newport Beach, who flunked twice and added, "I'm not a stupid person but they make you feel really stupid.") California is about to be hit by an aging population wave, and Steve Lopez is riding it. His column focuses on the blessings and burdens of advancing age -- and how some folks are challenging the stigma associated with older adults. "I had no problem," said 79-year-old Ruth Gleason of Ridgecrest, who added: "Thank you and Steve Gordon at the DMV for working to alleviate the test-taking fears for over-70 CA drivers."

Prostate cancer is a dominant health concern calling for advanced diagnostic tools. Utilizing digital pathology and artificial intelligence, this study explores the potential of 11 deep neural network architectures for automated Gleason grading in prostate carcinoma focusing on comparing traditional and recent architectures. A standardized image classification pipeline, based on the AUCMEDI framework, facilitated robust evaluation using an in-house dataset consisting of 34,264 annotated tissue tiles. The results indicated varying sensitivity across architectures, with ConvNeXt demonstrating the strongest performance. Notably, newer architectures achieved superior performance, even though with challenges in differentiating closely related Gleason grades. The ConvNeXt model was capable of learning a balance between complexity and generalizability. Overall, this study lays the groundwork for enhanced Gleason grading systems, potentially improving diagnostic efficiency for prostate cancer.

Advances in digital pathology and artificial intelligence (AI) offer promising opportunities for clinical decision support and enhancing diagnostic workflows. Previous studies already demonstrated AI's potential for automated Gleason grading, but lack state-of-the-art methodology and model reusability. To address this issue, we propose DeepGleason: an open-source deep neural network based image classification system for automated Gleason grading using whole-slide histopathology images from prostate tissue sections. Implemented with the standardized AUCMEDI framework, our tool employs a tile-wise classification approach utilizing fine-tuned image preprocessing techniques in combination with a ConvNeXt architecture which was compared to various state-of-the-art architectures. The neural network model was trained and validated on an in-house dataset of 34,264 annotated tiles from 369 prostate carcinoma slides. We demonstrated that DeepGleason is capable of highly accurate and reliable Gleason grading with a macro-averaged F1-score of 0.806, AUC of 0.991, and Accuracy of 0.974. The internal architecture comparison revealed that the ConvNeXt model was superior performance-wise on our dataset to established and other modern architectures like transformers. Furthermore, we were able to outperform the current state-of-the-art in tile-wise fine-classification with a sensitivity and specificity of 0.94 and 0.98 for benign vs malignant detection as well as of 0.91 and 0.75 for Gleason 3 vs Gleason 4 & 5 classification, respectively. Our tool contributes to the wider adoption of AI-based Gleason grading within the research community and paves the way for broader clinical application of deep learning models in digital pathology. DeepGleason is open-source and publicly available for research application in the following Git repository: https://github.com/frankkramer-lab/DeepGleason.

The application effect of artificial intelligence (AI) in the field of medical imaging is remarkable. Robust AI model training requires large datasets, but data collection faces communication, ethics, and privacy protection constraints. Fortunately, federated learning can solve the above problems by coordinating multiple clients to train the model without sharing the original data. In this study, we design a federated contrastive learning framework (FCL) for large-scale pathology images and the heterogeneity challenges. It enhances the model's generalization ability by maximizing the attention consistency between the local client and server models. To alleviate the privacy leakage problem when transferring parameters and verify the robustness of FCL, we use differential privacy to further protect the model by adding noise. We evaluate the effectiveness of FCL on the cancer diagnosis task and Gleason grading task on 19,635 prostate cancer WSIs from multiple clients. In the diagnosis task, the average AUC of 7 clients is 95% when the categories are relatively balanced, and our FCL achieves 97%. In the Gleason grading task, the average Kappa of 6 clients is 0.74, and the Kappa of FCL reaches 0.84. Furthermore, we also validate the robustness of the model on external datasets(one public dataset and two private datasets). In addition, to better explain the classification effect of the model, we show whether the model focuses on the lesion area by drawing a heatmap. Finally, FCL brings a robust, accurate, low-cost AI training model to biomedical research, effectively protecting medical data privacy.

Cox unveiled a new feature that empowers people with disabilities to control their TV with their eyes. The Accessible Web Remote for Contour gives those who have lost fine motor skills – whether from degenerative conditions or paralysis – the ability to browse the video guide with a glance. Specifically, a free web-based remote control is navigable using various assistive technologies owned by customers, including eye gaze hardware and software, switch controls, and sip-andpuff systems, which the user controls by gently blowing into a tube. Eye-tracking technology gives people living with conditions like paraplegia, Parkinson's disease and amyotrophic lateral sclerosis (ALS) the same access to their TVs as customers with the latest edition of Contour. "Innovative technology like this gives people with disabilities an added level of independence," said Steve Gleason, founder of Team Gleason and former New Orleans Saints football player who has been living with ALS since 2011.